SPECIAL BULLETIN COVID-19 #222 Now Available

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles pertaining to COVID-19:

SPECIAL BULLETIN COVID-19 #222: FDA Approves Remdesivir (Veklury) for Qualifying Pediatric Patients

On Jan. 21, 2022, the FDA approved authorization of Remdesivir (Veklury) for the treatment of COVID-19 in pediatric patients. More information

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.